Phase 4 N=88 Optimizing Body Composition for Function in Older Adults
Obesity · Overweight With Indications for Weight Loss
Primary: Appendicular Non-bone Lean Mass — -2.53; -2.49; -2.04; -1.45 kg
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=40 Assessment of Body Composition and Physical Function
Body Composition · Physical Function
Primary: Fat Mass — 44.71 Kg
N/A N=138 Evaluation of the Accuracy of a Computer Vision-based Tool for Assessment of Total Body Fat Percentage
Obesity
Primary: Comparison of Body Fat Percentage Estimates to DXA References Classified by Body Mass Index — 2.50; 6.36; 5.75; 7.66 Total Body Fat Percentage
N/A N=362 Validation of the Stayhealthy BC1 Body Comp Analyzer
Body Composition
Primary: Percent Body Fat — 20.3; 20.4; 32.8; 33.4 percent body fat — p=0.001
Phase 1 N=22 PED NEONAT 20-000599 Fetal Body Composition
IUGR · Gestational Diabetes · Pregnancy Related
Primary: Maternal Visceral Adipose Tissue Volume — 97593; 169626; 96787 mm3
Phase 3 N=164 Calorie Restriction and Changes in Body Composition, Disease, Function, and Quality of Life in Older Adults
Obesity · Diabetes · Hypertension
Primary: Change in Abdominal Fat Mass — -192.6; -21.9; -275 Cubic cm
Phase 4 N=131 Effect of Orlistat in Body Composition
Obesity · Overweight
Primary: Change From Baseline to Week 24 in Abdominal VAT Mass — -0.630; -0.403 kg — p=0.0244
N/A N=20 Safety of Body Composition Analysis in Heart Failure Patients With Implantable Cardioverter Defibrillators (ICDs)
Heart Failure · Obesity
Primary: Number of Participants With Arrhythmia as Detected by ICD — 0 participants
N/A N=150 Generation of Prediction Equations for BIA of the Elderly
Healthy Elderly
Primary: Total Body Water — 1.85 liter
N/A N=10 Measurement of Body Fat in Infants
Brown Adipose Tissue · Body Composition
Primary: Whole Body Fat Mass — 20.8 percentage of fat mass
N/A N=65 Effects of Daily Supplementation of 5-HTP on Body Composition
Body Composition
Primary: Body Composition — 14.6; 12.6; 58.4; 57.7 Kilograms
N/A N=50 Whole-body Vibration With or Without Localized Radiofrequency and Body Composition in Obese Female
Obesity
Primary: Body Composition — 44.8; 43.4; 44.0 PECENTAGE OF WHOLE-BODY FAT
N/A N=120 Comparing Medical Body Composition Analyzer Seca mBCA 555 With Seca mBCA 515
Bioelectrical Impedance Measurement of Healthy Adults
Primary: SMM — 0.34 kg
N/A N=29 Clinical Effectiveness of Body Fat Distribution Imaging in Real-World Practice: The BODY-REAL Study
Overweight and Obesity · PreDiabetes · Type 2 Diabetes
Primary: Change in BMI — 0.43; 0; 4.4; 0 kg/m2 — p=0.2
Phase 4 N=60 The Effects of Formula Diet on Body Weight, Body Composition, and Biomarkers for Disease Compared to a Standard Diet
Body Weight Changes
Primary: Body Weight Loss (kg and Percent) at Months 3 and 6
N/A N=187 Utilizing Protein During Weight Loss to Impact Physical Function
Obesity · Weight Loss · Diet Modification
Primary: Change in Expanded Short Physical Performance Battery Score — 0.06; 0.11; 0.16 score on a scale — p=0.16
Phase 4 N=139 Use of Electrical Impedence to Measure Lean Body Weight as a Determinant of the Dose of Contrast Media for Abdominal CT
IV Contrast Dosing
Primary: Difference in Enhancement of the Liver and Blood Vessels Over Time, Measured in Hounsfield Units (HU) — 116; 124; 121; 120 Hounsfield units (HU)
N/A N=298 Application of Bioimpedance Spectroscopy in Taiwan Dialysis Patients
Fluid Overload
Primary: All-cause Hospitalization — 0.52; 0.54 hospitalizations per patient-year
N/A N=164 Framingham State Food Study
Obesity · Diabetes · Cardiovascular Disease
Primary: Total Energy Expenditure, Assessed by Indirect Calorimetry Using Stable Isotopes — 2713; 2504; 2640; 190 kcal/d
N/A N=30 Low-calorie Diet and Body Composition Prior to Roux-en-Y Gastric Bypass
Morbid Obesity · Liver Fat
Primary: Change in Intra-hepatocellular Lipid Content (IHCL) Following the Pre-operative Diet — 40.0; 67.4; 0.1 percentage of change in IHCL
N/A N=63 Cellular Dynamics of Subcutaneous Fat Distribution in Obese Women
Obesity · Metabolic Syndrome
Primary: In Vivo Adipose Cell Formation (Adipogenesis) — -0.3; 1.8; -1.2; 2.1 percent
Phase 2 N=72 Nutrition and Body Composition in Acute Lymphoblastic Leukemia
Precursor Cell Lymphoblastic Leukemia-Lymphoma · Vitamin D Deficiency
Primary: Change in Serum Vitamin D Level (Group A) — 5.5; -0.30; 1.0; 26.5 ng/ml
N/A N=47 Antecedents of Obesity: Fetal Measures of Adiposity
Obesity
Primary: Infant Adiposity at 24-72 Hours Following Birth — 11 Percentage of total body weight
N/A N=65 Dietary Essential Fatty Acid Regulation of Omega-3 HUFA Metabolism; Satiety and Body Composition
Weight Gain · Healthy Subjects · Obesity
Primary: Proportion of n-6 HUFA in Total HUFA (%n-6 in HUFA) — 80.0; 81.3; 80.5 Percentage of total HUFA
N/A N=40 Diagnostic Ultrasound for Measuring Fat of the Body
Subcutaneous Fat
Primary: Difference in Thickness of Subcutaneous Fat at Different Anatomic Sites on the Body — .56; .60; .83; 1.65 average fat measurement (cm)
N/A N=39 The Effect of Protein-enriched Diet on Body Composition and Appetite
Overweight · Obese · Metabolic Syndrome
Primary: Change in Lipid Content of the Liver (Intrahepatocellular Lipid) — 27.9; 9.3; 21.4; 5.9 % IHCL — p=<0.05
N/A N=12 Body Composition Changes With Albuterol and Caffeine Versus Placebo in Adolescents
Pediatric Obesity
Primary: Change in Fat Mass With Caffeine/Albuterol — 0.97; -0.21 kg
N/A N=187 Utilizing Protein During Weight Loss to Impact Physical Function and Bone
Obesity · Weight Loss · Diet Modification
Primary: 18-month Change From Baseline in Total Hip Trabecular Volumetric Bone Mineral Density Assessed by Computed Tomography (CT) in mg/cm^3 — -0.91; -1.77; -0.03 mg/cm^3…
N/A N=21 Time Course Adaptations Using Deuterated Creatine (D3Cr) Method
Sarcopenia
Primary: Muscle Mass — 3.47; 1.19 Kg — p=0.03
N/A N=10 Novel Approach to Assess Metabolic Flexibility in a Respiratory Chamber
Diabetes Mellitus, Type 2
Primary: Overnight Respiratory Exchange Ratio — 0.832; 0.887 ratio